All In Biotech

Drug Trial Radar · NCT01613963

Causes of Visual Loss in Retinal Disease

Observational Study of Visual Outcomes in Retinal Disease

Last checked: Nov 20, 2026Latest source record: Jun 7, 2012 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

2,000

Planned (sponsor's estimate)

Start

May 2012

Primary completion

Dec 2012

Study completion Dec 2012

Sponsor

Lead sponsor
Royal Surrey County Hospital NHS Foundation TrustAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jun 7, 2012

More drug trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 16 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a study of visual outcomes in retinal disease that seeks to identify the causes of visual loss. This data will be used to predict which patients are at risk of losing vision and how they can be better treated.

Conditions

  • Uveitis
  • Scleritis

Interventions

  • Immunosuppressive AgentsDrug

    Treatment with systemic corticosteroids and/or immunosuppressive agents Treatment with local corticosteroids and other drugs

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Visual acuity at 5 yearsTime frame: 5 years

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Moorfields Eye Hospital

    London, London, United Kingdom

  • Royal Surrey County Hospital

    Guildford, UK, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.